跳至主要内容
临床试验/NCT04412902
NCT04412902已完成不适用

Predictors of Recurrence for High Risk Endometrial Cancer Patients

Far Eastern Memorial Hospital1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2020年4月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
1
主要终点
Factors affecting overall survival

研究概览

简要总结

This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.

详细描述

The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high.The investigators retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01~2019/09/17.

排除标准

  • Patients with stage I endometrial cancer do not have high risk factors.

结局指标

主要结局

Factors affecting overall survival

时间窗: 10 years

Factors affecting overall survival

次要结局

  • Factors affecting progression-free survival(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheng-Mou Hsiao

Chief of Department of Obstetrics & Gynecology

Far Eastern Memorial Hospital

研究点 (1)

Loading locations...

相似试验

Predictors of Recurrence for High Risk Endometrial... | 临床试验